Medicxi Ventures Management as of Dec. 31, 2025
Portfolio Holdings for Medicxi Ventures Management
Medicxi Ventures Management holds 5 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 59.8 | $499M | 20M | 25.01 | |
| Phathom Pharmaceuticals (PHAT) | 14.8 | $124M | 7.5M | 16.59 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 12.1 | $101M | 2.9M | 35.08 | |
| Rapt Therapeutics | 11.3 | $95M | 2.8M | 33.87 | |
| Aura Biosciences (AURA) | 2.0 | $17M | 3.0M | 5.45 |
